Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Scientific Reports
|
May 31, 2018
Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients
G Montes Diaz, J Fraussen, B Van Wijmeersch, et al.
Autoimmunity Reviews
|
February 26, 2009
B cell characterization and reactivity analysis in multiple sclerosis
J Fraussen, K Vrolix, P Martinez-Martinez, et al.
Journal of Autoimmunity
|
August 25, 2010
A novel method for making human monoclonal antibodies
J Fraussen, K Vrolix, P Martinez-Martinez, et al.
European Journal of Neurology
|
December 27, 2015
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index
L de Bock, J Fraussen, L M Villar, et al.
Clinical Immunology (Orlando, Fla.)
|
January 7, 2024
Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab
L Beckers, P Baeten, V Popescu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Scientific Reports
|
May 31, 2018
Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients
G Montes Diaz, J Fraussen, B Van Wijmeersch, et al.
Autoimmunity Reviews
|
February 26, 2009
B cell characterization and reactivity analysis in multiple sclerosis
J Fraussen, K Vrolix, P Martinez-Martinez, et al.
Journal of Autoimmunity
|
August 25, 2010
A novel method for making human monoclonal antibodies
J Fraussen, K Vrolix, P Martinez-Martinez, et al.
European Journal of Neurology
|
December 27, 2015
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index
L de Bock, J Fraussen, L M Villar, et al.
Clinical Immunology (Orlando, Fla.)
|
January 7, 2024
Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab
L Beckers, P Baeten, V Popescu, et al.
Page
of 1